ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0061178;regulation of insulin secretion involved in cellular response to glucose stimulus;10.0;0.8933024483968273;0.861892236059334;9.54514264355307;231.89735718708792;5.769740442447999;0.0077613958509799305;0.7103058064080809;[PRKCE, FKBP1B, CFTR]
GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;5.602686357784832;0.007979625599047746;0.6615216408886768;[PDGFA, CCL5, PDGFD, PDGFC, FYN, PDGFRB, PDGFRA, TGFB2, F2R, SIRT1, PTK2, DCN, FGR, SELP, GH1, KIT, CD28, PTPN6, TEK]
GO:0008584;male gonad development;5.0;1.0;0.7902410118609202;9.628524252492122;50.96471695749156;5.2552850506314295;0.001705743211299806;0.5589965337459591;[HMGB2, LRP2, GATA3, MEA1, HOXA11, HOXA10, CTNNA1, PDGFRB, LHCGR, TGFB2, RRM1, BIK, INHBA, EIF2S2, KITLG, SFRP2, NASP, MSH2, KIT]
GO:0035162;embryonic hemopoiesis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;36.11381869205153;6.832634648514029;0.0012086970112962418;0.6725415662651573;[FLT3LG, GATA3, KITLG, KIT]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[CD86, CD80, SLA2, FGF5, IMPA2, PDGFRB, PDGFRA, GAB1, TTC7B, VAV1, EREG, BTC, LCK, KIT, HBEGF, PDGFA, SOCS2, CD19, FYN, ICOS, TRAT1, EGF, KITLG, CD28]
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;1230.2749798860389;5.618190544320798;0.04117619640118775;0.7197434780388068;[CSF1R, CD40, IFNA2, GHR, CCL5, FYN, IL6R, LYN, LIF, GH1, IL6, IFNG, KIT]
GO:0051091;positive regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.431813958246067;277.8307104044464;4.2636448815154875;0.00929874384583087;0.650471949850128;[PHB2, TNF, CLU, PYCARD, AKT1, TNFSF11, BTK, PRKCQ, S100A8, CARD11, BEX1, TNFRSF11A, NHLH2, NLRP3, S100A12, FZD1, TGFB1, JUP, NFKB1, IL6, COPS5, JMY, MYD88, CD40, ITGB2, CD36, MYOCD, CHUK, ANXA3, NFAM1, IRAK3, TRAF1, PSMA6, IL1B, KIT, TLR6, TLR4, LTF, TLR2, NLRC4, NOD2, CD40LG]
GO:0071380;cellular response to prostaglandin E stimulus;8.0;1.0;0.875;9.628524252492122;704.3614414198233;6.943860283624253;0.023574343560179453;0.7301093378270707;[P2RY6, PTGER2, PRKCE, AKT1, PTGDR]
GO:0007259;JAK-STAT cascade;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;26.42836680105094;6.221725566191056;8.845336528452411E-4;0.6690987000520388;[LYN, PRL, GHR, SOCS2, GH1, STAT4, CCL2, CCR2]
GO:0006687;glycosphingolipid metabolic process;7.0;0.6763753087927167;0.6891070196535589;9.040737587590003;147.45961877692685;5.734022359845919;0.004935340735422783;0.64415753539903;[GAL3ST1, GM2A, PSAP, ITGB8, KIT]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[, LRRK2, TNF, GHR, PROK2, TNFSF11, MAP4K1, MAP2K2, SYK, DUSP6, MDFIC, IL1B, KIT, TLR4, C5AR1, FPR1, CXCR4, TGFA, NOD2, IQGAP3, THBS1, NTF3, CCL19, DRD4, MAP2K6, EGF, MAPK14, BMP2, CD40LG, CDK1, CSPG4, PKN1]
GO:0010811;positive regulation of cell-substrate adhesion;5.0;0.7980440201809971;0.6892630219514189;9.0094850440859;35.30989762708448;5.049685808968129;0.0011817904967337807;0.5484821789659555;[DOCK5, NRP1, CYR61, EMILIN2, CCR7, EMILIN1, CD36, PRKCE, OLFM4, DNM2, CCDC80, MMRN1, CEACAM6, NINJ1, COL8A1, EPB41L5, FLNA, JUP, CCL21, FN1, TEK]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[AKT1, MEF2A, MEF2C, PRKAR1B, AGTR1, FPR1, PDGFA, FPR2, GATA3, IQGAP3, PRKAR2B, SFN, LYN, ABCA1, JUN, HACE1, AZU1, COL1A2, ARHGAP6, ARHGAP4, DUSP1, GMIP, SIRT1, DUSP6, PTAFR, STAT4, DMD, PKN1, LGR4, CTGF, KCNH1, KCNH2, MSH6, ADCYAP1, MSH2, BLK, LY96, SOCS2, TNFRSF10B, BMX, CORO2A, NFKB1, LRRK2, TNFRSF1B, LCP2, LCP1, DTL, PPP1R15A, IL2RG, CCL5, E2F1, CCL2, E2F2, FYN, E2F7, SH2B1, IL2RB, PTPN6, TNFSF11, PAQR3, MIF, EREG, BTC, BTK, EPHA2, RACGAP1, CD14, PAG1, CCR1, PTK2, RGL4, CD24, RGL1, CD40, BRCA1, BRCA2, CCR9, RAC2, CTSH, CCR7, CCR6, CD36, CCR5, SPTAN1, CCR2, LAT2, MC3R, IL1B, KIT, DEPDC1, YAP1, PCNA, GNAI2, PAK1, PERP, KITLG, FKBP1B, RAMP1, CD80, CELSR1, CCRL2, PDGFRB, PDGFRA, DOK3, CARD11, CALCA, PSEN2, RASGRP4, SPTA1, CCNB1, ECT2, VCAM1, GH1, TNFAIP3, GHR, GRM5, ARHGEF12, IRAK3, CCNA2, NDUFS4, SHANK3, BCL2A1, EPS8L1, EGF, MAPK14, TEK, CYFIP1, EPS8, STMN1, CYP1B1, DAPK1, PRKCE, PRKCD, DEPDC1B, ADCY9, LGALS12, PRKCQ, HMOX1, PLCG1, PLK2, PLK1, ITK, CDKN1A, NFAM1, PAX2, CIT, HBEGF, GSN, CCL20, CARD9, IL5RA, TNF, SLC8A1, FGF5, PYCARD, GRAP2, STK32B, MEN1, LHCGR, MAP2K2, IGFBP5, DGKZ, NRBP1, RAB32, MELK, CSF1R, CALCRL, CUL5, MAP2K6, DHCR24, BCL6, CNOT3, CDK1, CSPG4, LAT, TREM1, CHUK, TFDP1, IL3RA, CX3CR1, NOD2, RAB21, PLN, DNAJA3, EDNRB, PPP2R1A, CHEK1, RPS6KA1, SOX4, PTGDR, TIAM2, SIK1, INPP5D, TP53BP2, CCR10, PRL, RALGPS2, MAP4K1, RHOG, RHOH, AVPR1A, VAV1, RAB33B, TLR8, TLR7, RHOU, SGK1, TLR4, PTGER2, CXCR5, CXCR4, CXCR6, CXCR1, CXCR2, PDPN, MLH1, CAMK4, SIPA1, SIRPG, ARHGDIA, ARHGDIB, TSC2, ATP1B1, CSF2RB, ADRB2, TGFB1, SELE, NFKBIA, SELP, ARHGAP30, JMY, DOCK5, DOCK4, MCTP1, CXCL1, TMEM100, BLNK, PTGIR, TGFBR3, ZAP70, CAMK2D, NCAM1, TSHR]
GO:0086003;cardiac muscle cell contraction;5.0;1.0;0.7902410118609202;9.628524252492122;20.959081145343944;9.083926447120524;7.014815839862524E-4;0.7547934328124444;[CAMK2D]
GO:0098909;regulation of cardiac muscle cell action potential involved in regulation of contraction;6.0;1.0;0.8231203125901445;9.628524252492122;24.09825301254981;7.697632086000634;8.065468413103714E-4;0.7167775754447168;[CAMK2D, CAV1]
GO:1904343;positive regulation of colon smooth muscle contraction;10.0;1.0;0.9152410118609203;9.628524252492122;112.16807620771051;9.777073627680469;0.00375416456595737;0.9152410118609203;[KIT]
GO:0002371;dendritic cell cytokine production;4.0;0.8933024483968273;0.6966512241984136;9.405380701177911;31.58806594444361;9.777073627680469;0.0010572241397468415;0.75;[KIT]
GO:1904349;positive regulation of small intestine smooth muscle contraction;10.0;1.0;0.9152410118609203;9.628524252492122;112.16807620771051;8.67846133901236;0.00375416456595737;0.8590579283277371;[GHSR, KIT]
GO:0007268;chemical synaptic transmission;7.0;0.7369933605727446;0.7194160455435727;8.663443356448536;23.173347188538074;3.922001705478042;7.755910757418987E-4;0.5514907148670789;[CHRM2, GABRB1, CHRM1, GRIK3, GRM5, CHRNB4, KCND2, NPY1R, SLC5A7, SLC1A3, SLC1A6, GJC1, SV2A, NPY, HRH4, KCNMB3, SLC17A6, GABRE, DRD4, EGR3, HTR1E, GABRA5, PCDHB15, PCDHB14, PCDHB10, P2RX1, PNOC, PCDHB16, PLP1, PMP22, PCDHB4, PCDHB8, GPR19]
GO:0007266;Rho protein signal transduction;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;29.60642063139588;5.334422371190153;9.9090025448413E-4;0.6478026081386739;[CELSR1, ARHGAP6, ARHGAP4, EPS8, PAK1, ARHGDIA, PDPN, ARHGDIB, RAC2, EPS8L1, ARHGEF12, CHUK, RHOG, RHOH, COL1A2, BCL6, AGTR1, RHOU]
GO:0008354;germ cell migration;5.0;0.9326813400603323;0.7565816818910864;9.510741216835738;40.540081573954176;7.57984905034425;0.0013568400465755524;0.6778748447945537;[TGFB1, CXADR, KIT]
GO:0009967;positive regulation of signal transduction;6.0;0.44130843764162375;0.5437745314109563;6.712834686611667;140.23187634019237;2.4492930892588385;0.004693434700611163;0.44837727507861835;[, SLA2, AKT1, WLS, ATF3, FPR1, PDGFA, FPR2, GATA3, SLC30A10, IQGAP3, PDGFD, PDGFC, SFN, LYN, JUN, JAG1, JUP, COL1A1, NOX4, GPR18, EZH2, ARHGAP6, ARHGAP4, JPH2, GPR37, SIRT1, F3, DUSP6, MMP12, NTF3, FLNA, BIK, LRG1, PKN1, LGR4, CTGF, RUVBL1, ADCYAP1, MAL, S100A8, LY96, TNFRSF11A, SOCS2, ZNF423, LY86, TNFRSF10B, NFKB1, CXCL10, CXCL11, PTPRC, HPSE, MYD88, LRRK2, ITGB3, FASLG, HHEX, ADAMTS20, ACPP, CCL8, CCL7, CCL5, CCL4, E2F1, CCL2, CCL1, FYN, SH2B1, PRRX1, TIE1, PTPN6, FCGR2B, LGALS1, TNFSF11, EPHB1, ACTN4, MIF, EREG, BTC, SFRP4, SFRP2, EPHA3, NAIP, EPHA2, TGFA, CD19, TSPAN5, CD14, PAG1, CCR1, TNFSF14, TNFSF12, PTK2, CD28, CD24, NRP1, ECM1, CD40, CD3E, AKAP12, CTSH, CCR7, CD36, SYK, GAB1, BANK1, IL1B, KIT, YAP1, GNAI2, PAK1, PPP1CA, NLRP12, KITLG, IL18R1, CD86, CD80, IL6R, PDGFRB, PDGFRA, CARD11, RASGRP4, ECT2, CAV2, CAV1, INHBA, GH1, IL6, BMP2, TNFAIP3, GHR, NUP62, YWHAH, MYOCD, MMP9, ELF3, CHI3L1, SHANK3, EGF, MAPK14, CD4, TEK, CYFIP1, PHB2, EPS8, PROK2, CYP1B1, PRKCE, PRKCD, DEPDC1B, DAAM2, SEH1L, S100A12, HMOX1, ICOS, ELANE, NDFIP2, FZD5, PLK2, FZD8, TGFB1I1, TIMP2, TIMP3, HAVCR2, FCRL2, FCRL3, NFAM1, HBEGF, ENG, CCL13, GPNMB, CCL19, CCL18, CCL23, GSN, CCL21, CCL20, CARD9, G0S2, SULF2, PF4, TNF, FGF5, PYCARD, CDH3, GRAP2, MEN1, MAP2K2, IGFBP5, CD180, F2R, ADAM9, CSF1R, NACC2, PSAP, DRD4, MAP2K6, CDK1, CSPG4, CCDC22, LAT, PLEKHF1, TREM2, PTPN22, CYR61, CHUK, TFDP1, LCK, XCL1, NLGN1, NOD2, CSK, P2RX5, IL1RN, PPP2R1A, SKP2, SOX4, IL1R1, POR, TP53BP2, SH2D1A, LIF, MARCO, ITM2C, IFNA2, PRL, ESM1, MAP4K1, ZDHHC17, VAV1, TLR1, MDFIC, TLR7, TLR6, TLR5, TLR4, TLR2, CXCR4, CTNNA1, SORBS1, CD40LG, F2RL3, GOLT1B, GHSR, C5AR1, ADRB2, STAP1, TGFB2, TGFB1, SELP, LIN28A, CXCL9, BLNK, ARAP1, AXIN2, DCN, TGFBR3, FGR, ZAP70, IFNG, PDE5A, LTF, DLL1, THBS1, TRAT1, LTBR]
GO:0046627;negative regulation of insulin receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;294.34753946768484;6.311337724880743;0.009851547250396369;0.6736814700148209;[PID1, PRKCD, TSC2, SLA2, SOCS2, PTPRE, IL1B, PRKCQ]
GO:0071361;cellular response to ethanol;6.0;1.0;0.8231203125901445;9.628524252492122;330.81194821622347;7.138016298065211;0.011071978195372667;0.6881587980249038;[SPI1, CCL7, PRKCE]
GO:0006605;protein targeting;9.0;0.7192862368539868;0.7558837436072825;9.182237149863703;93.4429707305496;4.015022244900292;0.0031274521371376313;0.6015690495021188;[HOMER3, AKAP12, HSD17B4, SCARB2, CLU, LAMP2, HGS, SLC27A2, EHHADH, NUP54, NLGN1, VPS41]
GO:0001558;regulation of cell growth;5.0;0.5833093054345528;0.5818956645781967;7.6590836060266145;26.25041167864861;3.793137346993279;8.785776550476476E-4;0.4842222321850823;[CDA, CYFIP1, CPNE5, KIAA1109, PPP2R1A, DPYSL2, RPS6KA1, AKT1, SFRP2, MAP1B, AGTR1, PRKCQ, EPB41L3, SFN, FN1, NRP1, CDKN1A, ARHGAP4, ESM1, AVPR1A, SIRT1, IL17RB, CEACAM1, SGK1, HBEGF, PAK1, FRZB, CDKN2C, KIF26A, SIPA1, SEMA5B, CTGF, CXCL16, TNR, IGFBP5, S100A8, SOCS2, IGFBP7, TGFB2, TGFB1, SYT2, CRIM1, INHBA, CXCL12, BCL6, CYR61, TCHP, MYOCD, DCC, DNM2, PSRC1, NDUFS3, FBP1, CAMK2D, TAF9, RAB21, SEMA4B]
GO:0010666;positive regulation of cardiac muscle cell apoptotic process;10.0;1.0;0.9152410118609203;9.628524252492122;149.5070754231924;7.474488534686424;0.005003867266781941;0.7974867031240476;[CAMK2D, CXCR2]
GO:0035669;TRAM-dependent toll-like receptor 4 signaling pathway;14.0;1.0;0.9759193652572005;9.628524252492122;827.3894261470873;9.083926447120524;0.027691979491003143;0.9404717862087245;[PRKCE]
GO:0086091;regulation of heart rate by cardiac conduction;8.0;1.0;0.875;9.628524252492122;61.172773623059015;6.193554689224359;0.002047397681241798;0.6917386748366816;[DSP, KCNH2, CAMK2D, JUP, KCNE3, KCNQ1, CAV1, KCNA5]
GO:0120072;positive regulation of pyloric antrum smooth muscle contraction;10.0;1.0;0.9152410118609203;9.628524252492122;112.16807620771051;9.777073627680469;0.00375416456595737;0.9152410118609203;[KIT]
GO:0051259;protein complex oligomerization;5.0;0.7763722522362496;0.6784271379790451;9.089527751759436;40.42272244673708;3.6012063575747084;0.0013529121422039536;0.47440687246051283;[CDA, TCL1A, TNFSF11, MCCC2, MIF, CLDN3, KCTD12, MGST1, ACMSD, CD79B, CD79A, HMOX1, VASP, JUP, COL1A1, EHD3, COL1A2, CD3G, CD3E, CD3D, TK1, FCER1G, KCND2, ARG1, KCNA5, CTNNA1, GCH1, GOPC, KCNG2, CHRNB4, OLFM4, BLM, ACAT1, NACC2, NLRP3, ECT2, CAV2, CAV1, TNFAIP3, ALAD, NUP62, EMILIN1, ADSL, VWF, NUP54, ACPP, FBP1, COLEC12, NLGN1, CAMK2D, HM13, NLRC4, NOD2, SAMHD1, PLN, CCL5, RRM1, MARCKS, RAD51, P2RX1, IMPDH2, TEK, CD247, RBMX]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[CD86, CD80, TNF, FGF5, TNFSF11, CCR7, PDGFRB, PDGFRA, IGFBP5, GAB1, F3, VAV1, EREG, BTC, LCK, KIT, CHI3L1, HBEGF, ENG, PDGFA, GATA3, THBS1, CD19, FYN, CCL19, ICOS, TGFB1, CCL21, TRAT1, EGF, PTK2, KITLG, LIN28A, CD28, NOX4, TEK, HPSE]
GO:0007193;adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.117698628726131;28.36322711391944;5.334422371190153;9.492916862557204E-4;0.6478026081386739;[CHRM2, GABBR1, CHRM1, GPR37, HTR1E, NPY1R, GRIK3, FPR2, GNAI1, GNAI2, AKAP12, MARCO, GRM5, ADCY9, RGS1, HRH4, PSAP, FLNA, S1PR3, DRD4]
GO:0040015;negative regulation of multicellular organism growth;6.0;1.0;0.8231203125901445;9.628524252492122;145.8359341853073;7.379178354882098;0.004880997473362539;0.7004918368257019;[SOCS2, ADRB2]
GO:0035023;regulation of Rho protein signal transduction;9.0;0.8436909121759173;0.8180860812682478;9.318369324188282;48.758993290020136;4.879233827729558;0.0016319196251719597;0.645764870037956;[NRP1, ARHGEF10L, EPS8, ARHGDIA, STMN1, ARHGDIB, PDGFRB, PLEKHG1, ARHGEF12, F2R, ARAP3, VAV1, TIAM2, FGD3, FGD4, EPS8L1, ECT2, ABCA1, BCL6, DLC1, GPR18, F2RL3]
GO:0090036;regulation of protein kinase C signaling;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;45.070113835906206;7.069023426578259;0.001508456149618737;0.7124295520356204;[AKAP12, CD40]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MEF2C, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, PDGFA, IQGAP3, PDGFD, PDGFC, HMOX1, NCKAP1L, PLCG1, ELANE, LYN, JUN, FN1, CDC6, CDKN1A, HOXC10, TIMP1, HLA-DPA1, HAVCR2, ANXA1, ARG1, FCRL3, SIRT1, F3, PAX2, MMP12, HBEGF, PTAFR, KCNA5, PTGS2, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, LRG1, HLA-DPB1, CHRM1, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, IGFBP5, F2R, MSH6, ADCYAP1, CD274, CSF1R, BLM, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, BCL6, CDK1, HPSE, ITGB3, FASLG, CYR61, TNFSF13B, LBH, ITGA4, XCL1, BIRC5, CX3CR1, SMARCD3, LRP2, NOD2, CCL5, E2F1, CTHRC1, PRRX1, KLF5, PRC1, DNAJA3, PTPN6, AQP1, CDC20, TCL1A, EDNRB, SKP2, TNS3, ICOSLG, SOX4, FLT3LG, MIF, RUNX2, EREG, BTC, SFRP2, TGFA, TWIST1, CD1D, PKHD1, EGR1, EGR3, TNFSF12, TNFSF13, LIF, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, ECM1, CD40, CTSZ, PRL, CD3E, BMI1, ESM1, RAC2, CTSH, CCR2, SYK, RHOG, PDCD1LG2, AVPR1A, NME1, HCK, CEACAM6, IL1B, KIT, YAP1, GNAI2, PURA, PAK1, CXCR2, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IL6R, PDGFRB, GHSR, PDGFRA, CCNE2, CCNE1, PRTN3, CARD11, C5AR1, LTBP3, DPP4, CCNB2, CCNB1, TGFB2, TGFB1, VCAM1, CAV2, NR4A1, IL6, BMP2, LIN28A, NR4A3, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, MMP2, GLP2R, MMP9, TGFBR3, CCNA2, ZAP70, IFNG, NDUFS4, LTA, LTF, DLL1, THBS1, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, TEK]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[IL1RN, GOLT1B, TNF, LGALS1, AKT1, TNFSF11, WLS, PRKCE, F2R, CARD11, S100A12, HMOX1, ECT2, NDFIP2, PLK2, TNFRSF10B, CCDC22, MYD88, ECM1, CD40, FASLG, NUP62, CCR7, CD36, CHUK, ZDHHC17, IL1B, TLR6, LTF, NOD2, FLNA, FYN, CCL19, CCL21, CARD9, CD4, LTBR]
GO:0045666;positive regulation of neuron differentiation;8.0;0.6181399273706679;0.684069963685334;8.712233520617966;337.32148776029015;3.9481280100702625;0.011289846625707336;0.576907450041722;[SCARB2, CYFIP1, CPNE5, PLXND1, FMR1, ARHGDIA, MEF2C, ADCYAP1, MAP1B, EPHA3, SOCS2, ECT2, LYN, FZD1, SYT2, FN1, BMP2, CXCL12, LIN28A, BCL6, FES, PLXNB2, TCF4, EZH2, ROBO2, NRP1, TIMP2, NME1, SHANK3, NLGN1, RAB21, PAK1, CNR1, FYN, FKBP1B]
GO:0007595;lactation;6.0;1.0;0.8231203125901445;9.628524252492122;25.956233089099676;5.9928839937622085;8.687317623989867E-4;0.6295966787287501;[VDR, ABCB4, CAV1, CAD, PRL, NME1, SOCS2, ATP7B]
GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis;10.0;1.0;0.9152410118609203;9.628524252492122;384.64074149301706;4.886724499458715;0.01287357946357817;0.6651483300191682;[CYFIP1, CD3G, IGHG1, FCGR3A, SYK, PRKCE, PRKCD, VAV1, FGR, HCK, PAK1, IGKC, IGLV1-44, NCKAP1L, FYN, PLCG1, LYN, PTK2, FCGR2A, CD247, FCGR2B, IGKV3-20]
GO:0038093;Fc receptor signaling pathway;7.0;0.8436909121759173;0.7727648213451592;9.474373572664863;77.78262967477835;4.556717802602145;0.0026033146153928975;0.5839501255913225;[CYFIP1, IGHG1, FCGRT, GRAP2, PRKCE, PRKCD, CLEC4D, BTK, PRKCQ, CARD11, IGLV1-44, NCKAP1L, PLCG1, LYN, JUN, PTK2, NFKB1, NR4A3, IGKV3-20, LAT, ITK, CD3G, FCGR3A, FCER1A, FCER1G, CHUK, SYK, FOS, VAV1, LAT2, FGR, HCK, KIT, LCP2, PAK1, IGKC, FYN, FCGR1B, FCGR2A, CD247, FCGR2B]
GO:0097067;cellular response to thyroid hormone stimulus;6.0;0.8933024483968273;0.7697715367885581;9.485423408851448;110.48347060425422;7.004484905440688;0.003697782332456301;0.6813299963962409;[GHSR, KIT, CTSH, GAS2L1, CTSS, CTSB]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[IL5RA, TNF, FGF5, TNFSF11, MEN1, PDGFRB, MEF2A, PDGFRA, MEF2C, MAP2K2, PAQR3, EREG, BTC, PDGFA, CSF2RB, IQGAP3, RASGRP4, SPTA1, MAP2K6, TGFB1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, MAP4K1, CHUK, DUSP6, IL1B, KIT, IL3RA, SHANK3, HBEGF, CAMK2D, NOD2, IL2RG, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, KITLG, IL2RB, TEK]
GO:0050730;regulation of peptidyl-tyrosine phosphorylation;9.0;0.6873818243518346;0.7399315373562063;9.0689084645567;111.97076766282173;4.31748811353631;0.003747560826526104;0.6170371680902661;[CD80, PPP2R1A, IL6R, PRKCE, PRKCD, MIF, EREG, SFRP2, CSF1R, TGFA, PDGFA, PDGFD, PDGFC, STAP1, LYN, TGFB1, ACE, CAV1, LIF, BST1, GH1, IL6, CSPG4, CD24, NRP1, CD40, ITGB3, IFNA2, ITGB2, TREM2, CD3E, GHR, GRM5, CD36, SYK, IFNG, BANK1, KIT, HBEGF, CCL5, NTF3, FYN, EGF, CD4, PTPN6]
GO:0071277;cellular response to calcium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;5.433268205826786;0.0026274528238337297;0.6009779013089371;[CPNE8, NLGN1, CAMK2D, CPNE5, SERPINE1, PHB2, ECT2, KCNH1, MEF2A, MEF2C, JUN, FOS, TUBG1]
GO:0010634;positive regulation of epithelial cell migration;8.0;0.7866048967936545;0.7683024483968273;9.383401794459138;242.52723865374625;4.901876304479318;0.00811716841739676;0.6256821821716325;[DOCK5, NRP1, NRP2, CD40, SPARC, ITGB3, AKT1, CTSH, CCR6, ANXA1, ANXA3, PRKCE, MMP9, SIRT1, IFNG, ADAM9, PFN1, HBEGF, GATA3, PTGS2, THBS1, EPB41L5, HMOX1, PLCG1, JUN, TGFB2, TGFB1, PLK2, TEK]
GO:0032024;positive regulation of insulin secretion;10.0;0.9326813400603323;0.8815816818910864;9.59953671561887;1037.3763533530775;5.514393750639154;0.03472005296862251;0.6972473647141411;[BLK, SOX4, PRKCE, CFTR]
GO:2000650;negative regulation of sodium ion transmembrane transporter activity;10.0;0.8259837884571596;0.8282329060895002;9.464221201200845;676.2962608223798;7.292166977892469;0.02263502722260573;0.7881627702307852;[CAMK2D, PRKCE]
GO:0060374;mast cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;47.07409398820286;8.67846133901236;0.0015755275618510598;0.7669372290569613;[KIT, GATA3]
GO:2000273;positive regulation of signaling receptor activity;7.0;0.7140352122741334;0.7079369713942671;8.965230035081857;204.98744489530804;6.311337724880743;0.006860745303922797;0.6736814700148209;[EGF, PRKCE, TGFA, ADRB2, EREG, SHANK3]
GO:0043410;positive regulation of MAPK cascade;10.0;0.6634067003016617;0.7469443620117512;9.174268980214526;1017.2390743488962;3.4929394666096676;0.03404607636272706;0.5938700986216354;[, IL1RN, PHB2, PROK2, TNFSF11, EPHB1, PRKCE, MIF, EPHA3, EPHA2, FPR1, TGFA, PDGFA, FPR2, SLC30A10, IQGAP3, PDGFD, PDGFC, S100A12, ELANE, CCR1, JUN, FZD5, LIF, FZD8, MARCO, NOX4, CD24, EZH2, NRP1, CD40, TIMP2, CCR7, CD36, HAVCR2, MAP4K1, GPR37, SYK, FCRL3, DUSP6, MDFIC, BANK1, IL1B, KIT, TLR6, TLR4, CCL13, CXCR4, GNAI2, PAK1, GPNMB, NTF3, CCL19, CCL18, CCL23, CCL21, CCL20, CARD9, CD40LG, PKN1, TNF, CTGF, PYCARD, PDGFRB, PDGFRA, MAP2K2, F2R, ADCYAP1, ADAM9, CSF1R, C5AR1, TNFRSF11A, ADRB2, PSAP, DRD4, MAP2K6, TGFB2, TGFB1, CAV2, GH1, IL6, BMP2, CDK1, CSPG4, LRRK2, TREM2, PTPN22, GHR, CHI3L1, XCL1, PDE5A, NOD2, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CSK, EGF, TIE1, MAPK14, CD4, LTBR, TEK, FCGR2B]
GO:0001541;ovarian follicle development;4.0;1.0;0.75;9.628524252492122;34.608406302298;6.166155715036245;0.001158312213394382;0.5653374900225189;[INHBA, ADCYAP1, KIT, CTNNA1, MMP19]
GO:0051279;regulation of release of sequestered calcium ion into cytosol;9.0;0.7369933605727446;0.7647373054666613;9.242861771680136;148.50473241193134;5.486614186532078;0.004970319748245178;0.676826329833192;[CXCL9, CAMK2D, CORO1A, SLC8A1, JPH2, PLN, CD19, DMD, PLCG1, SNCA, LYN, TGFB1, TRPC1, PRKCE, F2R, CXCL10, CXCL11, FKBP1B, XCL1, PTPN6, F2RL3]
GO:0051310;metaphase plate congression;6.0;0.8436909121759173;0.7449657686781032;9.34084218004034;45.439948165668724;5.948432231191374;0.0015208341718066008;0.6273234135236593;[SEH1L, CDCA5, CDCA8, CCNB1, NUP62, MLH1, GEM, NDC80, CENPE, CENPF, KIF18A, PSRC1, KIF2C]
GO:0010881;regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion;11.0;1.0;0.9324289523296623;9.628524252492122;219.4584201917244;6.8867018697843045;0.007345075824061613;0.7846152062148197;[CAMK2D, PLN, FKBP1B, DMD, SLC8A1]
GO:0010763;positive regulation of fibroblast migration;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;201.49065414776382;7.379178354882098;0.006743710864509851;0.7523715242355574;[PAK1, TGFB1, PRKCE, AKT1, THBS1, SLC8A1]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[IL5RA, SLA2, FGF5, EFEMP1, GRAP2, EPHB1, PDGFRB, PDGFRA, MAP2K2, PRKCD, EREG, BTC, MELK, BTK, EPHA3, EPHA2, BLK, CSF1R, CSF2RB, MAP2K6, LYN, LIF, BMX, CLK4, PTK2, CLK1, FES, ITK, GHR, SYK, FGR, ZAP70, HCK, LCK, KIT, IL3RA, HBEGF, FYN, CSK, IL12RB2, EGF, TIE1, WEE1, PTPN6, TEK]
GO:1904251;regulation of bile acid metabolic process;7.0;0.8259837884571596;0.7639112594857803;9.446202695698167;58.70275173925325;7.292166977892469;0.0019647282716661932;0.7238411236270654;[KIT, SIRT1]
GO:1905065;positive regulation of vascular smooth muscle cell differentiation;8.0;0.8653626801206646;0.8076813400603323;9.488762310116963;295.7578040146463;7.9853141584524145;0.009898747535627478;0.7833693374183408;[MYOCD, KIT, ENG]
GO:0038111;interleukin-7-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;6.832634648514029;0.00101047745553359;0.7003406189322132;[IL2RG, SOCS2]
GO:0002281;macrophage activation involved in immune response;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;81.79914540449643;7.379178354882098;0.0027377437822370863;0.7004918368257019;[CX3CR1, SUCNR1, SYK, PRKCE, HAVCR2]
GO:0046777;protein autophosphorylation;8.0;0.7763722522362496;0.7631861261181248;9.31486669363708;180.75330000196035;4.488806596985934;0.006049650283656873;0.604557778120715;[SLA2, GRAP2, AKT1, EPHB1, PDGFRB, PDGFRA, MAP2K2, DAPK1, VRK1, MELK, BTK, SIK1, BLK, CSF1R, LYN, BMX, EIF2S1, CLK4, PTK2, CLK1, FES, ITK, LRRK2, MAP4K1, SYK, CAD, IRAK3, FGR, ZAP70, HCK, LCK, KIT, CAMK2D, AURKB, PAK1, FYN, CSK, CAMK4, TEK]
GO:0008542;visual learning;8.0;1.0;0.875;9.628524252492122;51.65827414420079;5.970411137910149;0.00172895594617802;0.6803271032452366;[MEIS2, ADAM2, KIT]
GO:0003254;regulation of membrane depolarization;6.0;0.7248374789738407;0.6855390520770648;8.992535485772125;38.60784531422591;6.015873511986907;0.0012921698378621823;0.6307723637598831;[CAMK2D, LRRK2, IFI6, DCN]
GO:0043303;mast cell degranulation;9.0;1.0;0.896240625180289;9.628524252492122;196.3355458728175;7.138016298065211;0.006571174029843636;0.7612791106150483;[LAT2, NR4A3, KIT, LAT]
GO:0002320;lymphoid progenitor cell differentiation;5.0;0.8653626801206646;0.7229223519212526;9.223059144383958;22.164838071467113;7.379178354882098;7.418371831928127E-4;0.6676125360964777;[SPI1, KIT, GATA3, SOX4]
GO:1902514;regulation of calcium ion transmembrane transport via high voltage-gated calcium channel;9.0;0.8933024483968273;0.8428918493787028;9.474373572664863;60.15828078694383;7.57984905034425;0.002013443519001299;0.7838744581139225;[CAMK2D]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[F11R, TIAM2, DEPDC1B, LLGL2, EPHA2, RACGAP1, NCKAP1L, JUN, EZH2, ARHGAP9, DENND1B, NRP1, CD40, ARHGAP6, ARHGAP4, CCR7, RHOG, GMIP, VAV1, DEPDC1, CCL13, NTF3, CCL19, CCL18, RANBP2, RANBP1, CCL23, CCL21, CCL20, DLC1, SIPA1, CXCL13, RGS1, ARHGDIA, ARHGDIB, F2R, TSC2, ADCYAP1, ACAP1, PRTN3, ARHGAP19, ARHGAP15, ADAP2, ECT2, EVI5, CAV2, ARHGAP25, TBCK, ARHGAP30, ARHGAP11A, DOCK4, LRRK2, TAGAP, ARHGEF12, TBC1D9, ARAP3, ARAP1, AXIN2, ALDH1A1, XCL1, ASAP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1]
GO:0010739;positive regulation of protein kinase A signaling;8.0;1.0;0.875;9.628524252492122;237.72454511224748;7.57984905034425;0.007956426586706367;0.7626338329336335;[AKAP12, ADRB2, MIF]
GO:0097324;melanocyte migration;7.0;1.0;0.8509193652572005;9.628524252492122;24.971868181253015;9.083926447120524;8.357859548042604E-4;0.8154717862087246;[KIT]
GO:0002318;myeloid progenitor cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;22.164838071467113;8.390779266560578;7.418371831928127E-4;0.7193458537639684;[KIT, JAM3]
GO:0032762;mast cell cytokine production;5.0;1.0;0.7902410118609202;9.628524252492122;22.637273805675832;9.083926447120524;7.576491820522217E-4;0.7547934328124444;[KIT]
GO:0010613;positive regulation of cardiac muscle hypertrophy;8.0;0.8933024483968273;0.8216512241984136;9.485423408851448;95.57844489853944;6.444869117505266;0.003198924535738274;0.7045909063862833;[MEF2A, CAMK2D, TRPC3, PTK2, NR4A3, PDE5A]
GO:0031397;negative regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;529.4632463014641;5.572381008289503;0.01772065836772442;0.7002128357670632;[TNFAIP3, AKT1, FBXO5, SOX4, PRKCE, FYN, CAV1, MAD2L1]
GO:0051209;release of sequestered calcium ion into cytosol;14.0;0.7980440201809971;0.874941375347699;9.527428135620752;522.9340415463636;5.9928839937622085;0.01750213176047399;0.7823957313958061;[CCL21, PRKCE, F2R, FASLG, JPH2, PTPRC, LCK, FKBP1B, XCL1, CCR7, CCL19, CCR5]
GO:0071456;cellular response to hypoxia;6.0;1.0;0.8231203125901445;9.628524252492122;103.24589989147204;5.104244793218563;0.0034555473540902374;0.5841516286869992;[SUV39H1, MPL, PHB2, SLC8A1, AQP1, AKT1, KCND2, PRKCE, SIRT1, CCNA2, TWIST1, PTGS2, CCNB1, E2F1, HMOX1]
GO:0050910;detection of mechanical stimulus involved in sensory perception of sound;6.0;1.0;0.8231203125901445;9.628524252492122;83.9288867027761;7.379178354882098;0.0028090243068477775;0.7004918368257019;[COL11A1, KIT]
GO:0038109;Kit signaling pathway;8.0;1.0;0.875;9.628524252492122;61.193638670852046;9.083926447120524;0.002048096015614107;0.839552420951524;[KIT]
GO:0050996;positive regulation of lipid catabolic process;7.0;0.7248374789738407;0.7133381047441208;8.85533436425864;114.22740612088849;6.641579411751319;0.0038230884848748396;0.6905700452391912;[IL1B, PRKCE, PRKCD, TWIST1]
GO:0060396;growth hormone receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;7.292166977892469;0.0010376185600805164;0.747921758369865;[GHR, SOCS2, GH1, PTK2]
GO:0090303;positive regulation of wound healing;7.0;0.7043150770688792;0.7030769037916401;8.753055515138222;62.345319237194666;5.905872616772578;0.002086641727724376;0.6529459655301135;[SERPINE1, THBS1, MYLK, THBD, PDPN, CD36, ANXA1, PRKCE, F2R, F3, SELP, HPSE, TLR4, HBEGF]
GO:0035234;ectopic germ cell programmed cell death;5.0;1.0;0.7902410118609202;9.628524252492122;49.330608194382684;7.9853141584524145;0.001651051061600959;0.6986103492792611;[IL1B, KIT]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[MRGPRF, EDNRB, GPR171, C3AR1, AKT1, PROK2, HOMER3, PRKACB, PTGDR, TAS2R10, TAS2R13, TAAR2, TRHR, EREG, TIAM2, SFRP4, ADCY9, SFRP2, AGTR1, FPR1, FPR3, FPR2, OR7D2, CCR10, CCR1, ABCA1, FZD1, GPR15, FZD5, OR2J2, FZD8, AZU1, NMBR, PPBP, MARCO, PNOC, OR7C2, GPR18, GPR19, GPR25, GABRB1, GRIK3, CD3E, AKAP12, CCR9, RAC2, FFAR2, CCR7, CCR6, CCR5, CCR2, GPR37, ANXA1, RHOG, GPBAR1, TACR3, AGTRAP, PTH2R, GP1BA, AVPR1A, SORCS3, VAV1, MC3R, CCL13, PTGER2, PTAFR, CXCR5, CXCR4, CXCR6, GNAI1, GNAI2, FGD3, FGD4, CXCR1, FRZB, NPY, CXCR2, FLNA, CCL19, GABRE, CCL18, GPR157, P2RY13, GABBR1, CCL23, CCL21, SORT1, GABRA5, CCL20, P2RY14, GPR6, RAMP1, LGR4, F2RL3, PF4, CHRM2, CHRM1, CELSR1, CXCL13, CXCL16, RGS1, CCRL2, PDGFRB, CD97, GHSR, LHCGR, SPNS3, APLP2, F2R, NPY1R, DGKZ, ADCYAP1, SPNS1, OR2C3, CALCA, SUCNR1, CALCRL, GPR87, C5AR1, GPR85, GPR84, ADRB2, GPR82, HRH4, PSAP, ECT2, DRD4, HTR1E, CAV1, GPR98, CXCL10, CXCL11, CXCL12, GNB2, OR7E24, TAS2R7, CXCL6, CXCL9, OR1G1, CXCL1, CXCL3, CXCL2, CXCL5, GRM5, PDE4B, PTGIR, ARHGEF12, GLP2R, OR2H1, XCL1, CX3CR1, LRP1, OR1E1, P2RY6, CCL8, PLN, CCL7, CNR1, P2RY2, OR2W1, CCL5, CCL4, CCL2, S1PR3, OR12D3, CCL1, S1PR5, SLC12A2, TSHR, OR11A1, PTPN6]
GO:0030183;B cell differentiation;6.0;0.7307253602413294;0.6884829927108091;9.022388448921806;64.35544597283358;5.2552850506314295;0.0021539188605695985;0.5918758344751833;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, HHEX, LGALS1, BLNK, TPD52, CR2, IFNA14, ITGA4, IFNA16, NFAM1, ATP11C, MSH2, KIT, CARD11, IFNA10, DLL1, CD79B, CD79A, NKX2-3, IFNA21, VCAM1, CD40LG, BCL6, FCGR2B, ITM2A]
GO:0031274;positive regulation of pseudopodium assembly;9.0;0.9326813400603323;0.8625812952104552;9.571365838652174;200.71212349518538;7.212124270218933;0.006717654144200148;0.7650689957573628;[CCL21, KIT, CCR7]
GO:0043552;positive regulation of phosphatidylinositol 3-kinase activity;11.0;0.9326813400603323;0.8987696223598284;9.597752593825367;732.6859750532908;6.375876246018314;0.024522340210466318;0.7584915600596062;[LYN, PDGFRB, PDGFRA, TGFB1, CCL21, FPR2, NOD2, PTK2, FGR, KIT, CCR7, TEK, CCL19]
GO:0043278;response to morphine;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;93.3430750065417;6.280566066213989;0.0031241087171554015;0.6721078059595746;[ABCB4, PRKCE, TACR3, CNR1, IL1B]
GO:0046426;negative regulation of JAK-STAT cascade;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;286.97803335492995;5.845247994956144;0.009604896512927369;0.6951668794741764;[LRRC19, CAV1, LRRC4, GP1BA, PODN, DCN, SOCS2, FLRT2, HGS, PPP2R1A, LRRTM4]
GO:0060314;regulation of ryanodine-sensitive calcium-release channel activity;10.0;0.8933024483968273;0.861892236059334;9.56398573135455;427.81060936749446;6.518977089658987;0.014318436090978222;0.7486218033895181;[CAMK2D, JPH2, PLN, FKBP1B, DMD]
GO:0030217;T cell differentiation;6.0;0.657518819034173;0.651879722107231;8.679443697794976;65.04859315339479;5.132682728539097;0.00217711787291102;0.5856059460217904;[ITK, CD3G, PTPN22, CD3E, CD3D, CCR9, CCR6, SOX4, ANXA1, FCER1G, RHOH, RUNX2, VAV1, ZAP70, CLEC4D, LCK, KIT, BLM, GATA3, NKX2-3, EGR1, TGFB1, BCL11B, FZD5, FZD8, BMX, CD4, PTPRC, DNAJA3, CD28, GPR18, IL18R1]
GO:0007218;neuropeptide signaling pathway;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;26.976932752798508;5.123113277522946;9.028936615729279E-4;0.5851165638517994;[CALCA, SORT1, NPY1R, GPR84, SORCS3, ADCYAP1, NPY, PNOC, PROK2, GPR19]
GO:0030218;erythrocyte differentiation;5.0;0.8436909121759173;0.712086467948879;9.117698628726131;22.675663695230284;5.885253329569843;7.589340571069517E-4;0.5912131408273906;[SPI1, GATA3, LYN, INHBA, KLF1, TGFBR3, KIT, ACIN1, TRIM10]
GO:0002327;immature B cell differentiation;7.0;0.8436909121759173;0.7727648213451592;9.420884887713877;65.04859315339267;8.16763571524637;0.002177117872910949;0.7686126355688037;[KIT, ATP11C]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, IQGAP3, JUN, JAG1, JUP, FN1, AZU1, NR2F2, COL1A1, LRRC32, HOXC10, FOS, SIRT1, MMP12, CKS2, PTAFR, STAT4, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, CTGF, RUVBL2, ADCYAP1, PKP3, BLM, FOXO1, ZNF423, NFKB1, CXCL10, MYD88, CIITA, HHEX, ITGB8, PPP1R12A, PEG3, PPP1R15A, CCL5, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, EIF3E, EIF3D, CCNH, TNFSF11, SFRP4, SFRP2, EGR1, EGR2, EGR3, ID1, CD28, CD40, BRCA1, BRCA2, CD3E, CD3D, CTSH, CD36, CD34, RGMA, IL1B, KIT, YAP1, IL17A, CD86, CD80, ACTG2, CCNE1, CCNB1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, TCF4, HMGB2, ARHGEF10L, NUP62, YWHAH, MYOCD, ACTA2, CCNA2, PSRC1, ELF3, CREB5, TAF9, EGF, MAPK14, CD4, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, TGFB1I1, PAWR, SERPINB9, PAX5, PAX2, ENG, EPCAM, GSN, NR1H2, GTF2H1, PLP1, PF4, PLXND1, FMR1, TNC, TNF, CLU, CDH3, CDH1, MEN1, MAP2K2, F2R, ADAM2, COPS5, MAFF, CDK1, PTPN22, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, SMARCD3, CEBPE, NOD2, ABLIM3, POLR2E, POLR2K, POLR2L, KLF4, KLF1, KLF5, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, BEX1, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, RHOG, MDFIC, TLR6, TLR4, TLR2, LILRB1, GRHL2, CAMK4, ARID4A, ARID4B, HOXA11, HOXA10, HGS, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, SLC40A1, CKAP2, AXIN2, DCN, DNM2, IFNG, DLL1, THBS1, LUM, MEIS2, MEIS1, RBMX]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[BRCA2, CTGF, RUVBL2, PDGFRB, GHSR, ANXA1, DUSP1, TACR3, CCNA2, IL1B, PCNA, ABCB4, PTGS2, SOCS2, RBBP8, TGFB1, NR2F2, COL1A1, GH1, CD4, KIF18A, EZH2]
GO:0031663;lipopolysaccharide-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;6.343086423195323;8.87013979980389E-4;0.647506047256038;[PTAFR, LY96, PTPN22, TNF, CCL5, AKT1, CCL2, CD14, LYN, TGFB1, PRKCE, MAPK14, NFKBIA, HCK, CD6, IL1B, TLR4, TLR2]
GO:0010863;positive regulation of phospholipase C activity;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;83.73920694943958;6.139487467954083;0.0028026758962042993;0.6889736746265369;[PDGFRB, ITK, PDGFRA, C5AR1, PTAFR, AVPR1A, SELE, RASGRP4, KIT, PLCG1]
GO:0032870;cellular response to hormone stimulus;5.0;0.6039883530135606;0.5922351883677006;7.932074963068391;80.94247679971589;3.9540277321974506;0.0027090718549867714;0.49245017396659174;[CYFIP1, PID1, TNC, AQP1, RUVBL2, AKT1, PRKACB, PTGDR, MEN1, GHSR, LHCGR, MEF2C, PRKCE, PRKCD, ADCYAP1, POR, ADCY9, PRKAR1B, SIK1, ABCB4, SLC30A10, FOXO1, SOCS2, PRKAR2B, IGFBP7, GAS2L1, JUN, TGFB1, CAV1, CDC6, INHBA, NFKB1, NR4A2, NR4A1, KIF18A, NR4A3, ROBO2, CTSS, GHR, CTSH, CTSB, ANXA1, DUSP1, ARG1, GLP2R, AVPR1A, FOS, CCNA2, CEACAM1, KIT, PTGER2, P2RY6, PAK1, FYN, CSK, SORBS1, TSHR, RAMP1]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[IL1RN, SERPINE1, CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, PLAU, VSTM1, TNFSF11, MEF2C, IFNA14, IFNA16, DAPK1, PRKCE, PRKCD, FLT3LG, MIF, EREG, BTC, ADCYAP1, SFRP2, IFNA10, CALCA, TGFA, PDGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, TNFSF13, LIF, INHBA, PPBP, GH1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PNOC, OGN, CD320, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, CXCL1, FASLG, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, IFNG, IL1B, LTA, XCL1, SHANK3, HBEGF, CCL13, NLGN1, CLEC12B, RETN, CCL8, TTR, GPNMB, CCL7, CCL5, NPY, CCL4, NTF3, CCL2, CCL1, CCL19, CCL18, CMTM8, CCL23, CCL21, EGF, CCL20, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[, AKT1, STK32B, MAP2K2, PRKCE, PRKCD, VRK1, PRKCQ, CCNB1, PLK2, PLK1, CLK1, CDK1, LRRK2, MAP4K1, CHUK, SYK, SGK1, CAMK2D, AURKB, MAPK14, CAMK4, PKN1]
GO:0018107;peptidyl-threonine phosphorylation;9.0;0.7671156992804218;0.7797984748205;9.305750860229072;337.99482745314367;5.395046993006588;0.011312382699260763;0.6721435792979885;[LRRK2, CHEK1, AKT1, PRKCD, CAD, VRK1, CAMK2D, CLK1, CDK1, PKN1]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[AKT1, CDCA3, BARD1, HACE1, PLK1, SIRT1, FBXW2, CUL5, SOCS2, MARCH3, MARCH1, BIRC5, DTL, NLRC4, RNF24, CDC20, SKP2, NAIP, BRCA1, BMI1, RNF144B, PDZRN3, PCNA, KLHL14, UBE2C, UBE2M, TNFAIP3, HIST1H2BK]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[SPARC, SERPINE1, MYLK, LGALS3, C3AR1, AKT1, IL1R1, PRKCE, ACTN4, PFN1, PDGFA, FPR2, GATA3, PLA2G7, EPB41L5, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, CCR1, JUN, TNFSF14, PLK2, FN1, PPBP, PTK2, COL1A1, NOX4, SNAI2, NRP1, NRP2, CD40, RAC2, CTSH, CCR7, CCR6, CCR2, ANXA1, ANXA3, GAB1, SIRT1, F3, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CCL21, CCL20, PF4, SEMA5B, ATP8A1, ITGA2B, CXCL13, TNF, SLC8A1, CXCL16, PYCARD, PLAU, IL6R, PDGFRB, PDGFRA, IGFBP5, F2R, ADAM9, CD274, CSF1R, CD151, C5AR1, CORO1A, TGFB2, TGFB1, SELP, CXCL10, CXCL11, IL6, BMP2, CXCL12, PTPRC, NR4A3, DOCK5, CXCL6, CXCL9, DOCK4, TNFAIP6, ITGB3, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, CYR61, ITGA4, MMP9, FGR, IFNG, XCL1, THBS1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL1, EGF, SEMA4B, LAMB1, MAPK14, TEK]
GO:0048170;positive regulation of long-term neuronal synaptic plasticity;10.0;1.0;0.9152410118609203;9.628524252492122;315.9495864907144;8.16763571524637;0.010574548323677036;0.8329342821725234;[KIT, SHANK3]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[CYFIP1, PLXND1, EPS8, TPM1, VRK1, CSF1R, ARHGAP15, CORO1A, SPTA1, EPB41L3, MYH14, MYH10, FN1, PTK2, FES, PLXNB2, ITGB2, ANXA1, RHOG, ARAP3, RHOH, ARAP1, FGR, HCK, KIT, ITGA7, RHOU, CCL13, FGD3, FGD4, CCL7, PDPN, CCL2, FYN, WASF3, DLC1]
GO:2001031;positive regulation of cellular glucuronidation;8.0;1.0;0.875;9.628524252492122;308.8393045332484;9.777073627680469;0.010336573585398964;0.875;[PRKCE]
GO:0032230;positive regulation of synaptic transmission, GABAergic;8.0;1.0;0.875;9.628524252492122;135.4246808583232;7.212124270218933;0.0045325421940280546;0.7438283705770736;[NLGN1, PRKCE]
GO:1901842;negative regulation of high voltage-gated calcium channel activity;12.0;1.0;0.9481203125901445;9.628524252492122;1677.0477324272201;8.390779266560578;0.05612927835936835;0.8772251544931927;[GEM]
GO:1901844;regulation of cell communication by electrical coupling involved in cardiac conduction;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;47.34252427509125;7.57984905034425;0.0015845116819816402;0.7626338329336335;[CAMK2D, CAV1]
GO:0006469;negative regulation of protein kinase activity;10.0;0.6835726970475526;0.7570273603846966;9.223059144383958;1097.0598301796;4.243684138952949;0.03671760522636433;0.6322632160784685;[PYCARD, PPP2R1A, AKT1, MEN1, PAQR3, PRKCD, TSC2, SFRP2, PRKAR1B, SOCS2, FLRT2, PRKAR2B, SFN, LYN, CAV1, PLK1, NR2F2, PTPRC, PKIG, CDKN1A, LRRC4, TNFAIP3, PTPN22, HHEX, DUSP10, LRRTM4, NUP62, DUSP2, MYOCD, DUSP1, IRAK3, GP1BA, SIRT1, DUSP6, DCN, CEACAM1, IL1B, LRRC19, CDKN2C, PODN, PTPN6, PKN1]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[LGALS1, SKP2, ESCO2, SPARCL1, SDC2, FN1, TF, SERPINA1, TIMP1, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, PSMC6, PSMC2, NUCB1, TNC, MEN1, IGFBP5, APLP2, FBXW2, PSMD14, CUL5, SOCS2, IGFBP7, NAE1, WFS1, IL6, COPS5, CCDC22, UBE2M, LAMC1, CYR61, DTL, LAMB1]
GO:0045747;positive regulation of Notch signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.56398573135455;187.6437959822434;5.926926025970411;0.006280268983073171;0.6540226378555745;[NOD2, DLL1, TSPAN5, TGFB2, JAG1, ELF3, KIT]
GO:1901725;regulation of histone deacetylase activity;10.0;0.8933024483968273;0.861892236059334;9.541512875502493;193.00745610492504;7.697632086000634;0.006459785860398609;0.8088982747154926;[CAMK2D, LRRK2]
GO:0009968;negative regulation of signal transduction;6.0;0.43649654099988644;0.5413685830900877;6.680044863788677;140.65047919891595;2.686163805600486;0.0047074449615745265;0.460490854527945;[, PID1, SERPINE1, SLA2, PHB2, STMN1, AKT1, HOMER3, UBASH3A, PRKACB, DAPK1, PRKCD, PADI2, PRKCQ, ATF3, GATA3, ADAMTS12, FLRT2, FIGNL1, PRDM16, HMOX1, LYN, FZD1, SNAI2, EZH2, TGFB1I1, LRRC4, TIMP2, TIMP3, DUSP2, DUSP1, ARG1, FCRL3, PAWR, SIRT1, DUSP6, AES, MMP12, PXDN, LRRC19, PTGS2, FRZB, NR1H2, TMEM64, SULF2, LGR4, PF4, TNF, CLU, PYCARD, RUVBL2, MEN1, TLE4, IGFBP5, CSF1R, LY96, FOXO1, SOCS2, WFS1, TNFRSF10B, PTPRE, CXCL12, PTPRC, BCL6, CCDC22, LRRK2, FASLG, PTPN22, HHEX, LBH, DUSP10, EMILIN1, PVRIG, CX3CR1, PPP1R15A, LRP1, LRP2, CCL5, FYN, CSK, CTHRC1, TIE1, KLF4, PTPN6, IL1RN, LGALS3, PPP2R1A, EPHB1, IL1R2, PAQR3, MIF, RUNX2, SFRP4, SFRP2, SIK1, EPHA3, EPHA2, TWIST1, APCDD1, PKHD1, INPP5D, CD14, EGR1, LIF, VNN1, NRP1, PTPRR, ECM1, BRCA1, CD3E, RHOH, GP1BA, CEACAM1, BANK1, IL1B, KIT, TLR6, TLR4, YAP1, IFI6, GNAI2, CTNNA1, PODN, NLRP12, KIF26A, DLC1, FKBP1B, GRINA, RGS1, PDGFRB, PDGFRA, TSC2, HGS, FBLN1, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, CAV2, CAV1, ARHGAP25, NR4A2, NFKBIA, IL6, BMP2, HMGB2, TNFAIP3, LRRTM4, NUP62, PTGIR, MYOCD, ARAP3, IRAK3, AXIN2, MMP9, DCN, DNM2, TGFBR3, NDUFS3, FBP1, PFDN5, LTF, BCL2A1, CLEC12B, TAF9, THBS1, SNCA, EGF, MAPK14, TEK]
GO:0048863;stem cell differentiation;4.0;0.7043150770688792;0.6021575385344395;8.242229891372231;21.066225782797595;5.734022359845919;7.050676185779127E-4;0.5432381701418294;[HHEX, EPCAM, FRZB, HOXA7, MEF2C, TGFB2, ACE, LIF, RUNX2, PAX2, LIN28A, KIT, HOXB4]
GO:0035855;megakaryocyte development;5.0;1.0;0.7902410118609202;9.628524252492122;66.38585475831493;7.069023426578259;0.0022218748153703875;0.6517511986393402;[MEIS1, KIT, PTPN6]
GO:0032469;endoplasmic reticulum calcium ion homeostasis;10.0;0.8259837884571596;0.8282329060895002;9.52844079393514;288.6919123283276;6.686031174322154;0.009662258499776054;0.7571649570480019;[CAMK2D, WFS1, GRINA]
GO:0032467;positive regulation of cytokinesis;7.0;0.7043150770688792;0.7030769037916401;9.015419779605713;142.0565341908292;6.193554689224359;0.004754504356786525;0.6676580400938822;[SVIL, PRKCE, CXCR5, TAS2R13, CDC6, AURKB, CIT, RACGAP1, NUP62, ECT2]
GO:0031532;actin cytoskeleton reorganization;6.0;1.0;0.8231203125901445;9.628524252492122;32.01253927882412;5.788089581116195;0.001071430880247358;0.6191234829421188;[NRP1, ANTXR1, PAK1, FLNA, CXADR, ANXA1, GAB1, KIT]
GO:0060333;interferon-gamma-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.514393750639154;0.00101047745553359;0.6329257181104212;[CIITA, IFI30, HLA-DPA1, IFNGR1, PRKCD, HCK, IFNG, HLA-DQB1, CAMK2D, PTAFR, NCAM1, FCGR1B, HLA-DQA2, HLA-DQA1, HLA-DRB4, VCAM1, HLA-DPB1, HLA-DRA, HLA-DRB1]
GO:0007286;spermatid development;5.0;1.0;0.7902410118609202;9.628524252492122;72.7828096339012;5.370354380416217;0.0024359751381706407;0.5648811846224242;[JAM3, KIT]
GO:1903078;positive regulation of protein localization to plasma membrane;8.0;0.8436909121759173;0.7968454560879586;9.434368238051164;218.50214452761784;5.845247994956144;0.00731307013817619;0.6739262542938873;[LRP1, TREM2, AKT1, PRKCE, RHOG, SORBS1, IFNG, EPHA3, EPHA2]
GO:0007565;female pregnancy;3.0;1.0;0.6981203125901445;9.628524252492122;32.8060485501291;5.299736813202263;0.0010979889214459554;0.4691490996802742;[IL1RN, PRL, THBD, TGFB1, IGFBP5, CAD, FOS, ADCYAP1, CLDN4, PNOC]
GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway;7.0;0.579397892394798;0.6406183114545996;7.564831067780425;28.111912685638995;3.5644675319289507;9.408804185094754E-4;0.533206400604739;[CYFIP1, SLA2, EPS8, STMN1, AKT1, EPHB1, EREG, BTC, BTK, EPHA3, EPHA2, SDC2, TGFA, PDGFA, SLC30A10, FLRT2, PDGFD, PDGFC, NCKAP1L, PLCG1, PAG1, LYN, PTK2, COL1A1, NRP1, ITK, PTPRR, NRP2, CD3E, SYK, GAB1, VAV1, HCK, KIT, HBEGF, PAK1, NTF3, SORT1, SORBS1, SULF2, NCF4, CTGF, FGF5, EFEMP1, GRAP2, AP2M1, PDGFRB, PDGFRA, TSC2, KIF16B, COL4A1, BLK, CSF1R, CUL5, RASGRP4, FOXO1, SOCS2, STAP1, TGFB1, CAV2, CRIM1, BMX, GH1, NR4A3, FES, CSPG4, ITGB3, GHR, BLNK, MMP2, MMP9, FGR, ZAP70, LCK, ESRP1, LCP2, REPS2, POLR2E, FYN, CSK, POLR2I, POLR2J, POLR2K, POLR2L, TRAT1, EGF, MAPK14, CD4, CD7, TEK]
GO:0007166;cell surface receptor signaling pathway;5.0;0.43360584258713153;0.507043933154486;5.906854975555195;23.17027026302992;2.006850423521684;7.75488093814194E-4;0.39287143584790796;[, SLA2, F11R, TRBC1, C3AR1, AKT1, PRKACB, WLS, MEF2C, HHLA2, FPR1, PDGFA, FPR3, FPR2, GATA3, SLC30A10, KLRK1, PDGFD, PDGFC, LYN, ABCA1, JUN, JAG1, HLA-DRB4, FN1, VANGL1, COL1A1, COL1A2, HLA-DRB1, SIGLEC9, LRRC4, CTLA4, HLA-DPA1, PTH2R, FOS, SIRT1, F3, LRRC19, PTAFR, KCNA5, PTGS2, FRZB, NTF3, STAT4, FLNA, IL12RB1, IL12RB2, P2RY13, CASP8AP2, P2RY14, USP9Y, TMEM64, HLA-DPB1, LGR4, NCF4, F13A1, CXCL13, CTGF, EFEMP1, AP2M1, LAG3, IFNA14, IFNA16, IFNA10, BLK, CD274, GPR87, TACSTD2, LY96, TNFRSF11A, CORO1A, FOXO1, SOCS2, TNFRSF17, ZNF423, IFNA21, GRIA4, GPR98, TNFRSF10C, TNFRSF10B, BMX, NFKB1, CXCL10, CXCL11, CXCL12, PTPRC, LCN2, HLA-DRA, MYD88, CIITA, ITGAM, ITGB5, ITGB4, LRRK2, ITGB3, ITGB2, FASLG, ITGAL, TNFSF13B, HHEX, FCGR3A, ITGAX, ITGB8, ITGB7, ITGB6, ITGA4, TNFRSF1B, ITGA7, BIRC5, LCP2, LCP1, IL2RG, TSPAN33, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, FCGR1B, CTHRC1, TSPAN15, TSPAN13, FCGR2A, IL2RB, PTPN6, CD247, FCGR2B, ICAM2, ICAM3, IFI30, TNFSF11, EPHB1, MIF, EREG, BTC, SFRP4, SFRP2, IFI27, BTK, EPHA3, EPHA2, SDC2, TGFA, CD19, TSPAN5, TSPAN2, CD14, PAG1, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, PPBP, PTK2, ID1, CD28, SDC1, CD24, IGHM, NRP1, PTPRR, NRP2, CD40, TNFRSF13B, GRIK3, CD3G, PTPRK, CD3E, CD3D, CCR9, FCER1A, CD37, CCR7, CCR6, MUC15, CD36, CCR5, CCR2, FCER1G, SYK, GAB1, RGMA, LAT2, IL1B, KIT, IGHD, GNAI2, PAK1, IGKC, PERP, SORT1, IL18R1, IL17A, CD86, CD80, TRAC, MPL, CELSR1, CCRL2, IL6R, PDGFRB, CD97, PDGFRA, THEMIS, GEM, OSCAR, CCNE1, CARD11, PSEN2, KIR2DL1, RASGRP4, VCAM1, CAV2, CRIM1, INHBA, GH1, IL6, BMP2, IGKV3-20, SIRPB1, GHR, GRM5, NUP62, MMP1, MMP2, IRAK3, MMP9, BCL2A1, SAMHD1, EGF, MAPK14, CD2, CD4, CD6, CD7, CD9, TEK, CDA, CYFIP1, CLEC10A, EPS8, STMN1, GPR171, HOMER3, DAPK1, PRKCE, PRKCD, HOXB9, DAAM2, PRKCQ, FLRT2, HMOX1, NCKAP1L, PLCG1, IGHA1, HLA-DQA2, HLA-DQA1, FZD1, FZD5, FZD8, GP6, SNAI2, CDK14, DENND1B, ITK, CDKN1A, TGFB1I1, ASGR2, TIMP1, ANXA1, IFNGR1, NFAM1, AES, FCER2, HBEGF, ENG, HLA-DQB1, CCL13, ALOX5, CCL19, CCL18, GPR157, CCL23, CCL21, CCL20, CARD9, G0S2, SULF2, ZYX, PLP1, PF4, SEMA5B, CSF3R, PLXND1, FMR1, ITGA2B, IL5RA, TNF, FGF5, PYCARD, CDH5, IGHG1, CDH3, FCGRT, GRAP2, IL13RA2, IL13RA1, TLE4, CLEC4D, ADAM9, CSF1R, CD151, CALCRL, CUL5, IGLV1-44, EIF2B3, BCL6, PLXNB2, CSPG4, LAT, PTPN22, ADAMTS1, CR2, CR1, CHUK, LCK, ESRP1, IL3RA, XCL1, CX3CR1, NOD2, P2RY6, PLN, P2RY2, POLR2E, CSK, POLR2I, POLR2J, POLR2K, POLR2L, SEMA4B, KLF4, P2RX5, P2RX1, MNDA, CLEC2D, IL1RN, EDNRB, ICOSLG, SOX4, ACSL1, IL1R1, IL1R2, FLT3LG, RUNX2, TLN1, PFN1, IGSF6, TWIST1, APCDD1, CD79B, CD79A, INPP5D, CCR10, LIF, NMBR, MARCO, IFNA5, ROBO2, IFNA4, IFNA7, IFNA2, PRL, IFNA8, FFAR2, GP1BB, GPBAR1, GP1BA, PDCD1LG2, LIME1, IL17RB, VAV1, HCK, CEACAM1, RHOU, TLR4, TLR2, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR2, LILRB1, LILRB2, SORBS1, LILRB3, PODN, KRT19, CD40LG, IL18RAP, ARHGDIA, TSC2, KIF16B, COL4A1, KLRF1, PRTN3, KLRB1, C5AR1, CSF2RB, ADRB2, STAP1, TGFB2, STIL, TGFB1, NR4A2, NFKBIA, NR4A3, FES, KLRD1, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, TMEM100, LRRTM4, BLNK, PDE4B, DCC, GLP2R, AXIN2, DCN, TGFBR3, FGR, ZAP70, IFNG, LTA, CAMK2D, CLEC12B, DLL1, REPS2, S1PR3, NCAM1, TRAT1, TSHR, LTBR]
GO:0038162;erythropoietin-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;8.390779266560578;0.00101047745553359;0.7800242071602487;[KIT]
GO:0002551;mast cell chemotaxis;8.0;1.0;0.875;9.628524252492122;95.22538104108446;8.16763571524637;0.0031871078061660985;0.7926932703116032;[KIT]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[PID1, SPI1, EHMT2, SLA2, SPIB, AKT1, MEF2A, MEF2C, ATF3, GATA3, JUN, JAG1, JUP, NR2F2, PKIG, EZH2, HOXC10, FOS, SIRT1, MMP12, MED23, CKS2, PTAFR, STAT4, ZNF467, USP9Y, ATAD2, PSMC6, PSMC2, PKN1, CCNT2, RUVBL2, RUVBL1, ADCYAP1, MAZ, FOXO1, ZNF423, NFKB1, CXCL10, CIITA, FASLG, HHEX, PPP1R12A, PEG3, LRP2, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, SMARCAL1, CCNH, UXT, TNFSF11, SFRP4, SFRP2, IFI27, TGFA, PCBP3, ZNF700, EGR1, EGR2, EGR3, ID1, CD28, ECM1, CD40, SUV39H1, BRCA1, PCSK6, BMI1, CD3D, CD36, RGMA, IL1B, KIT, YAP1, IL17A, NR3C2, LOXL2, CCNE1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, TCF4, MXD1, HMGB2, ARHGEF10L, MYOCD, ELF3, FBP1, CREB5, TAF9, AURKB, MAPK14, EHF, SERPINE1, HOXA9, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXA4, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, PRDM16, HMOX1, ELANE, NKX2-3, FZD1, NFE2, FZD5, PLK1, FZD8, SNAI2, CDKN1A, ZNF367, HAVCR2, BRD2, PAWR, PAX5, PAX2, AES, ENG, EPCAM, NR1H2, GTF2H1, ELP4, PF4, PLXND1, TNF, DACH1, MEN1, TLE4, NACC2, WFS1, HOPX, COPS5, BCL6, MAFF, CYR61, RFC1, CHUK, TFDP1, SMARCD3, CEBPE, NOD2, ABLIM3, RBBP8, KLF4, KLF1, KLF8, KLF5, DNAJA3, PPIL4, ZNF608, EDNRB, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, PFN1, BEX1, TWIST1, NHLH2, BCL11B, BCL11A, LIF, TOP2A, AHCTF1, PRL, XPO1, TLR4, TLR2, PURA, LILRB1, GRHL2, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, ADRB2, NLRP3, TGFB2, TGFB1, CBX4, NR4A2, NFKBIA, NR4A1, NR4A3, JMY, CREBZF, KDM5D, SLC40A1, TMEM100, CKAP2, DCN, TGFBR3, IFNG, CAMK2D, DLL1, HSPD1, SNCA, LUM, MEIS2, MEIS1, RBMX]
GO:0002026;regulation of the force of heart contraction;7.0;0.7192862368539868;0.710562483684194;8.763526815005518;26.867502833526505;6.444869117505266;8.992311406554274E-4;0.6805102716434839;[CAMK2D, PLN, CAV1, SLC8A1]
GO:0030318;melanocyte differentiation;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;22.857985252022832;6.8867018697843045;7.650361955340501E-4;0.6424272657460779;[MEF2C, EDNRB, KIT]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, MEF2C, DAPK1, PRKCD, CLDN7, PRKCQ, GATA3, SLC30A10, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, AZU1, SNAI2, CDKN1A, CHL1, TIMP1, ANXA1, DUSP1, ANXA5, SERPINB9, SIRT1, PAX2, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, PF4, TNF, CLU, CLEC5A, F2R, ADCYAP1, MSH2, CSF1R, BLM, CORO1A, FOXO1, SOCS2, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, CXCL12, COPS5, BCL6, CDK1, MYD88, LRRK2, FASLG, CYR61, TNFRSF1B, ADAMTS20, BIRC5, CX3CR1, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, IL1RN, SLC46A2, AQP1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB1, FLT3LG, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, NRP1, BRCA1, CTSH, CCR7, CCR5, FCER1G, HCK, RNF144B, CEACAM6, IL1B, KIT, YAP1, IFI6, GNAI2, CXCR2, PDPN, CTNNA1, LILRB1, CD40LG, GRINA, MAD2L1, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, STIL, CBX4, CAV1, NR4A2, NFKBIA, IL6, NR4A3, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, MMP9, NDUFS3, LTF, BCL2A1, TAF9, DLL1, THBS1, AURKB, HSPD1, SNCA, TEK]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, DAPK1, PRKCD, ATF3, HMOX1, SFN, PLCG1, BARD1, LYN, JUN, NOX4, CTLA4, TIMP3, ANXA1, DUSP1, PAWR, SIRT1, F3, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, CASP8AP2, GSN, BIK, G0S2, TNF, CTGF, PYCARD, F2R, MELK, MAL, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, PLEKHF1, FASLG, CYR61, ITGA4, TFDP1, LCK, NLRC4, CCL5, E2F1, CCL2, P2RX1, MNDA, PPP2R1A, SOX7, SOX4, TIAM2, SFRP4, SFRP2, IFI27, SIK1, INPP5D, TP53BP2, TNFSF12, ITM2C, TOP2A, CD40, CTSZ, CTSH, VAV1, IL1B, CXCR2, CTNNA1, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, FAP, DLC1, PDGFRB, NLRP3, ECT2, TGFB2, TGFB1, VDR, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, UBE2M, TNFAIP8, YWHAH, ARHGEF12, MMP9, DNM2, IFNG, LTA, CAMK2D, BCL2A1, THBS1, HSPD1, CNR1, SNCA, HSPE1, LTBR]
GO:0030838;positive regulation of actin filament polymerization;11.0;0.7866048967936545;0.8257314007264895;9.456673995565463;459.92540939869633;5.2552850506314295;0.01539328954657896;0.7011844742147011;[CYFIP1, LMOD1, PYCARD, CCR7, PRKCE, HCK, PFN1, NCKAP1L, VASP, GSN, CCL21, JMY]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, PYCARD, TNFSF11, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, EPHA3, EPHA2, CSF1R, C5AR1, PDGFA, FPR2, TNFRSF11A, SLC30A10, PDGFD, PDGFC, CCR1, JUN, TGFB1, MARCO, BMP2, NOX4, NRP1, TREM2, PTPN22, CCR7, CD36, HAVCR2, IL1B, KIT, CHI3L1, XCL1, CCL13, NOD2, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, TIE1, CD4, TEK]
GO:0030032;lamellipodium assembly;6.0;0.8933024483968273;0.7697715367885581;9.533214072687796;78.21732158183345;6.311337724880743;0.002617863362324714;0.6458824173477649;[CYFIP1, ABLIM3, NUP85, KIT, VCL, WASF3, SH2B1]
GO:0070257;positive regulation of mucus secretion;7.0;1.0;0.8509193652572005;9.628524252492122;117.31221734425756;7.9853141584524145;0.0039263343403711445;0.7592887026755414;[P2RY2, PRKCE]
